1. Home
  2. CMPS

CMPS

COMPASS Pathways Plc American Depository Shares

Logo COMPASS Pathways Plc American Depository Shares

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 12:05pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Founded: N/A Country:
United Kingdom
United Kingdom
Employees: N/A City: CHESIRE
Market Cap: 600.0M IPO Year: 2020
Target Price: $45.83 AVG Volume (30 days): 723.2K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.32 EPS Growth: N/A
52 Week Low/High: $5.01 - $12.75 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: